impact factor
logo
 

One year in review

 

One year in review 2017: primary Sjögren’s syndrome


1, 2, 3, 4, 5

 

  1. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  2. Rheumatology Unit, University of Perugia, Italy.
  3. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Italy.
  4. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. chiara.baldini74@gmail.com
  5. Rheumatology Unit, University of Perugia, Italy.

CER10335
2017 Vol.35, N°2
PI 0179, PF 0191
One year in review

Free to view
(click on article PDF icon to read the article)

This article is also available as an online CME course. The course has been granted 5 (five) CME credits.

The registration and fruition of the online course is free of charge, the fee of EURO 25.00 (=20.49 + VAT) must be paid in order to obtain the credits.

This activity is valid for credit from May 15, 2017 through May 14, 2018.

Click here for more information on the CME activity.

PMID: 28337967 [PubMed]

Received: 16/02/2017
Accepted : 17/02/2017
In Press: 15/03/2017
Published: 15/03/2017

Abstract

Primary Sjögren’s syndrome (pSS) is a complex and heterogeneous disease. Last year, a great deal of basic and clinical research was carried out in pSS. Following the previous reviews of this publishing series, we will herewith provide a critical digest of the most recent literature on pSS pathogenesis, clinical manifestations and treatment. More specifically, we will focus on the heterogeneity of the disease, on the underlying pathogenetic pathways and on the possible new targeted treatments on the horizon.

Rheumatology Article